.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Poster

EKP 150

In vitro testing of new antifungals: Ibrexafungerp susceptibility in echinocandin-resistant clinical Candida species.

Presented in

Eukaryotic Pathogens (FG EK)

Poster topics

Eukaryotic Pathogens (FG EK)

Authors

Alexander Maximilian Aldejohann (Würzburg, DE), Carolina Menner (Würzburg, DE), Nadja Thielemann (Würzburg, DE), Ronny Martin (Würzburg, DE), Grit Walther (Jena, DE), Oliver Kurzai (Würzburg, DE; Jena, DE)